Textilinin-1 is a Kunitz-type
serine protease inhibitor from Australian brown
snake venom. Its ability to potently and specifically inhibit human
plasmin (K(i) = 0.44 nM) makes it a potential therapeutic
drug as a systemic anti-
bleeding agent. The crystal structures of the human microplasmin-textilinin-1 and the trypsin-textilinin-1 complexes have been determined to 2.78 Å and 1.64 Å resolution respectively, and show that textilinin-1 binds to
trypsin in a canonical mode but to
microplasmin in an atypical mode with the catalytic
histidine of
microplasmin rotated out of the active site. The space vacated by the
histidine side-chain in this complex is partially occupied by a water molecule. In the structure of microplasminogen the χ(1) dihedral angle of the side-chain of the catalytic
histidine is rotated by 67° from its "active" position in the catalytic triad, as exemplified by its location when
microplasmin is bound to
streptokinase. However, when textilinin-1 binds to
microplasmin the χ(1) dihedral angle of this
amino acid residue changes by -157° (i.e. in the opposite rotation direction compared to microplasminogen). The unusual mode of interaction between textilinin-1 and
plasmin explains textilinin-1's selectivity for human
plasmin over
plasma kallikrein. This difference can be exploited in future
drug design efforts.